Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
62.4% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
19
users have liked this narrative
4
users have commented on this narrative
46
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
30.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
25
users have liked this narrative
5
users have commented on this narrative
70
users have followed this narrative
New
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
19.2% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Union Bank of India
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Digital Competition And Regulatory Hurdles Will Erode Value
Key Takeaways Overly optimistic growth expectations, combined with slow loan expansion and government intervention, may lead to revenue and profitability challenges versus market valuations. Increasing digital competition and regulatory demands are eroding cost advantages, limiting customer growth and constraining improvements in operational metrics.
View narrative
₹154.00
FV
14.9% undervalued
intrinsic discount
10.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
24
users have followed this narrative
14 days ago
author updated this narrative
RATIONAL
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
iHexagon Launch And France And China Facilities Will Open Markets
Key Takeaways The iHexagon launch and production expansion aim to boost revenue and efficiency in new markets, particularly Asia. Strategic focus on connected cooking and digital services is expected to enhance customer engagement, improving revenue and net margins.
View narrative
€755.79
FV
15.9% undervalued
intrinsic discount
7.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
14 days ago
author updated this narrative
Lupin
AN
AnalystConsensusTarget
Consensus Narrative from 37 Analysts
Launching Injectable Products Like Liraglutide Will Strengthen Future Prospects
Key Takeaways Lupin's focus on complex injectables, respiratory products, and biosimilars is set to boost margins and diversify revenue streams. Strategic acquisitions and ANDA filings aim to enhance revenue and earnings growth through an enriched product portfolio.
View narrative
₹2.23k
FV
17.0% undervalued
intrinsic discount
7.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
14 days ago
author updated this narrative
Continental
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Portfolio Optimization And EV Investments Will Shape Future Markets
Key Takeaways Strategic focus on high-growth, high-margin segments and portfolio optimization is expected to improve efficiency, margins, and long-term earnings growth. Investments in automation, e-mobility, and supply chain localization position Continental to capitalize on industry shifts while maintaining margin discipline and resilience.
View narrative
€82.21
FV
12.2% undervalued
intrinsic discount
1.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
14 days ago
author updated this narrative
True Corporation
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
Advancements In 5G And AI Will Improve Operational Efficiency And Customer Experience
Key Takeaways Network consolidation and modernization are expected to enhance customer experience, optimize coverage, and improve revenue and net margins. Expansion in 5G and beyond connectivity solutions could create new revenue streams and support long-term earnings growth.
View narrative
฿15.03
FV
25.5% undervalued
intrinsic discount
-0.26%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
14 days ago
author updated this narrative
Dr. Reddy's Laboratories
AN
AnalystConsensusTarget
Consensus Narrative from 39 Analysts
Investments In Biosimilars And NRT Will Expand Market Reach, Yet Regulatory Hurdles May Persist
Key Takeaways Strategic expansion in biosimilars and key product markets could drive revenue and improve margins. Increased investment in R&D for complex generics and GLP-1 assets aims to boost high-margin, innovative product offerings.
View narrative
₹1.26k
FV
5.0% undervalued
intrinsic discount
4.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
14 days ago
author updated this narrative
Delivery Hero
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Operational Efficiencies And Cost Control Signal Path To Sustainable Profitability
Key Takeaways Market expansion, customer experience, and subscription in Korea could boost revenue and profitability through increased order volumes and customer retention. Talabat's potential IPO may attract regional investors, contributing to MENA growth and strengthening Delivery Hero's balance sheet.
View narrative
€36.42
FV
31.2% undervalued
intrinsic discount
11.30%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
14 days ago
author updated this narrative
Cochlear
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
New Cochlear Implant Launch And Market Expansion Will Strengthen Future Prospects
Key Takeaways Focus on adult and senior markets in developed countries could drive revenue and net margin growth through increased sales volume. New product launches and geographic expansion, especially in Europe and emerging markets, support competitive positioning and incremental revenue growth.
View narrative
AU$290.56
FV
7.9% overvalued
intrinsic discount
10.32%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
30
users have followed this narrative
14 days ago
author updated this narrative
CG Power and Industrial Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Government And Utility Spending Will Drive Global Grid Modernization
Key Takeaways Strong order growth and capacity expansion position the company to benefit from power sector investment and infrastructure modernization trends in India and abroad. Margin improvement and global diversification efforts, including ventures in semiconductors, support earnings stability and long-term profitability through new revenue streams.
View narrative
₹738.75
FV
7.9% undervalued
intrinsic discount
22.77%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
14 days ago
author updated this narrative
Value any company in seconds
Popular companies